Is Kopran Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Kopran Ltd (KOPRAN.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Kopran Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kopran Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Kopran Ltd?

Muslim investors may consider investing in Kopran Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Kopran Ltd classified as HALAL?

Musaffa determines the Shariah status of Kopran Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Kopran Ltd updated?

The Shariah compliance status of Kopran Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Kopran Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Kopran Ltd?

You can check the latest Shariah compliance status of Kopran Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

KOPRAN.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 06, 2026

Report Source: 2026 3rd Quarter Report

Kopran Ltd. Stock Analysis KOPRAN.NS

India Health Care Micro Cap Report: Q3, 2026

Kopran Ltd. is a holding company, which engages in the manufacturing of pharmaceuticals and related products. The firm is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The firm's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. The company has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.

Key Statistics of Kopran Ltd (KOPRAN.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹155.50₹160.84

Today's Open

₹158.00

Volume

89.59K

P/E Ratio (TTM)

19.78

52 Week Range

₹107.00₹212.58

Market Cap

7.90B

Avg. Volume

224.31K

Dividend Yield

1.90%

Financial Metrics & Statements of Kopran Ltd (KOPRAN.NS)

FAQ's for Kopran Ltd (KOPRAN.NS)

According to Musaffa’s Shariah screening methodology, Kopran Ltd (KOPRAN.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.